SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-24-000204
Filing Date
2024-05-14
Accepted
2024-05-14 17:06:16
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDING MARCH 31, 2024 bivi-20240331_10q.htm   iXBRL 10-Q 946319
2 EXHIBIT 31.1 bivi-20240331_10qex31z1.htm EX-31.1 12094
3 EXHIBIT 31.2 bivi-20240331_10qex31z2.htm EX-31.2 12259
4 EXHIBIT 32.1 bivi-20240331_10qex32z1.htm EX-32.1 5279
5 EXHIBIT 32.2 bivi-20240331_10qex32z2.htm EX-32.2 5130
  Complete submission text file 0001520138-24-000204.txt   5084468

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bivi-20240331.xsd EX-101.SCH 48357
7 XBRL CALCULATION FILE bivi-20240331_cal.xml EX-101.CAL 54065
8 XBRL DEFINITION FILE bivi-20240331_def.xml EX-101.DEF 143260
9 XBRL LABEL FILE bivi-20240331_lab.xml EX-101.LAB 325881
10 XBRL PRESENTATION FILE bivi-20240331_pre.xml EX-101.PRE 270120
75 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20240331_10q_htm.xml XML 735198
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39015 | Film No.: 24945582
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)